Received Aug 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | D2343 | RL |
patient received Menveo 1 vial rather than 2 vial dose yesterday; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 12-week-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number D2343, expiry date 31-JAN-2026) for prophylaxis. On 24-JUL-2025, the patient received Menveo (right thigh). On 24-JUL-2025, an unknown time after receiving Menveo, the patient experienced inappropriate age at vaccine administration (Verbatim: patient received Menveo 1 vial rather than 2 vial dose yesterday). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK Receipt Date: 25-JUL-2025 A registered nurse reported that a 2-month-old patient received Menveo 1 vial vaccine rather than 2 vial doses yesterday which led to inappropriate age at vaccine administration.